Leerink Partnrs Issues Negative Estimate for Geron Earnings
Geron Co. (NASDAQ:GERN – Free Report) – Analysts at Leerink Partnrs decreased their Q1 2025 earnings per share estimates for shares of Geron in a report issued on Wednesday, February 26th. Leerink Partnrs analyst F. Khurshid now expects that the biopharmaceutical company will post earnings of ($0.04) per share for the quarter, down from their […]
Geron Co. (NASDAQ:GERN – Free Report) – Analysts at Leerink Partnrs decreased their Q1 2025 earnings per share estimates for shares of Geron in a report issued on Wednesday, February 26th. Leerink Partnrs analyst F. Khurshid now expects that the biopharmaceutical company will post earnings of ($0.04) per share for the quarter, down from their […]
